Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (symbol: MIR) is a leading provider of radiation detection, measurement, analysis, and monitoring products and services. Mirion serves a diverse range of markets including nuclear power, medical, military, and homeland security, ensuring the safety of people, property, and the environment from nuclear and radiological hazards for over 50 years.
Headquartered in the San Francisco Bay Area, Mirion operates facilities across Europe, Asia, and North America, making it a globally recognized entity in the realm of radiation safety solutions. The company is structured into two main segments:
- Medical Segment: This segment focuses on radiation oncology quality assurance, providing critical patient safety solutions in diagnostic imaging and radiation therapy centers. Mirion’s advanced technologies ensure precise and reliable results, significantly enhancing patient care and safety.
- Technologies Segment: Catering to nuclear energy, defense, laboratories, scientific research, and other industrial markets, this segment represents the largest portion of the company’s revenue. Mirion's products and services in this segment are vital for accurate measurement and analysis in high-stakes environments, contributing to scientific advancements and industrial safety.
Mirion Technologies’ recent achievements include the development of cutting-edge radiation detection tools and strategic partnerships aimed at enhancing global safety standards. The company’s commitment to innovation is underscored by its continuous investment in R&D, resulting in reliable and advanced products that meet the evolving needs of its diverse clientele.
Financially, Mirion Technologies has demonstrated solid performance, with a robust revenue stream primarily driven by the Technologies segment. The company’s global presence, coupled with its specialized expertise, positions it as a critical player in the fields it serves.
Mirion (NYSE: MIR), a global radiation detection and monitoring solutions provider, announced the completion of the redemption of its outstanding publicly traded warrants. As of May 20, 2024, Mirion redeemed the warrants at $0.10 each. Of the 18,749,779 warrants, 2,131 were exercised for cash, and 18,074,285 were exercised on a cashless basis, resulting in a total of 3,978,418 new common shares issued. The remaining 673,363 unexercised warrants were redeemed for $67,336.30. The public warrants ceased trading on the NYSE before the market opened on May 20, 2024. The private placement warrants remain unaffected and continue to be outstanding. The common shares continue to trade under the symbol 'MIR'. Additional details are available on Mirion’s Investor Relations website.
Mirion (NYSE: MIR) announced that its CEO Thomas Logan and CFO Brian Schopfer will present at Jefferies’ 2024 Global Healthcare Conference in New York, NY. The presentation is scheduled for June 6, 2024, at 4:00 PM ET.
The event will be webcast live and accessible via Mirion's investor relations website, with an archived version available within twelve hours post-event.
Mirion, a global provider of radiation detection solutions, is reminding investors of the redemption of its publicly traded warrants to purchase shares of Class A common stock. The deadline for exercising these warrants is May 20, 2024, with a redemption price of $0.10 per warrant. Holders must exercise their warrants by 5:00 p.m. New York City time on the Redemption Date to receive the redemption price. The fair market value for warrant exercise is determined based on the average last price per share of Common Stock for the 10 trading days ending on the third trading day prior to the redemption date.
Mirion announced its first quarter 2024 financial results, with revenues increasing by 5.8% to $192.6 million and a net loss of $26.5 million. Adjusted EBITDA rose to $39.5 million, and the company reaffirmed its full year guidance, expecting revenue growth of 5% to 7% and adjusted EPS of $0.37-$0.42.
FAQ
What is the current stock price of Mirion Technologies (MIR)?
What is the market cap of Mirion Technologies (MIR)?
What does Mirion Technologies do?
Where is Mirion Technologies headquartered?
What are the main segments of Mirion Technologies?
What markets does the Technologies segment serve?
Which segment generates the most revenue for Mirion Technologies?
How long has Mirion Technologies been in operation?
In which regions does Mirion Technologies have facilities?
What is the focus of the Medical segment?
What recent achievements has Mirion Technologies made?
How does Mirion Technologies contribute to scientific research?
